Relapsed/Refractory Multiple Myeloma: Hematology Journal Club
Back to Video Library
Hey there, great course, right? Do you like this course?
All of the most interesting lessons further. In order to continue you just need to purchase it
Enroll course
Session sections
Section 1
1
Once-Weekly Vs Twice-Weekly Carfilzomib Dosing in Patients with Relapsed and Refractory MM: Results if the randomized phase 3
2
Multiple Myeloma Case Presentation
3
Implememting Multiple Myeloma Clinical Trial Data Real-World practice: Tawam case Based Discussion
4
Hematology Journal Club 1.0: Panel Discussion
Questions
My Question
{{ comment.replies_count }}
Send
Load More
Back to Q&A List
Add Comment
{{ message }}
Send
Once-Weekly Vs Twice-Weekly Carfilzomib Dosing in Patients with Relapsed and Refractory MM: Results if the randomized phase 3
Lesson is locked. Please Buy course to proceed.
Completed
Multiple Myeloma Case Presentation
Questions
My Question